Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This ...

A new research paper was published in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregulation and ...

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in Pharmacological Research, show that an innovative drug effectively prevents ...

CIRT leads to temporary urinary function decline, normalizing within three months and stable for five years. Prostate volume decreases significantly without ADT, remaining reduced for five years. T ...

Among patients with prostate cancer who received MRI-guided stereotactic body radiation therapy (SABR), more than 80% demonstrated “classic” neurovascular bundle patterns and over 96% showed more than ...

A more precise form of prostate cancer surgery nearly doubles the chances of men retaining erectile function afterwards compared with standard surgery, according to the first comprehensive trial of ...

Washington, March 25, 2026 (GLOBE NEWSWIRE)-- After 45, prostate health becomes one of the most significant factors shaping a man's quality of life. Frequent bathroom trips, disrupted sleep, weakening ...

Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S.